ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Clinical trials for ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus therapy takes on lung cancer after standard treatment fails
Disease control Recruiting nowThis study tests a new approach for people with advanced non-small-cell lung cancer whose disease has worsened after initial chemotherapy and immunotherapy. Participants receive an experimental virus (Olvi-Vec) followed by chemotherapy plus an immunotherapy drug, or the standard …
Matched conditions: ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New pill targets common cancer driver in advanced tumors
Disease control Recruiting nowThis early-phase study tests a new experimental drug called BGB-53038 in people with advanced or metastatic solid tumors that have a specific genetic change (KRAS mutation or amplification). The drug is a pan-KRAS inhibitor, meaning it aims to block many forms of the faulty KRAS …
Matched conditions: ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 13, 2026 16:02 UTC